Excess Mortality for Femoral Intertrochanteric Fracture Patients Aged 50 Years and Older Treated Surgically and Conservatively in Tianjin, China: A Cohort Study

Abstract

Objective:: Intertrochanteric fracture is one type of hip fracture, which is the most serious consequence of osteoporosis. Along with the growing elderly population, intertrochanteric fracture is expected to rise increasingly. The aim of this study was to assess excess mortality after intertrochanteric fractures and to identify the predictors of long-term mortality by therapy among patients aged 50 years and older in Tianjin.

Methods:: This is a retrospective cohort study on mortality for 3029 patients aged 50 years and older in Tianjin experiencing an intertrochanteric fracture between December 26, 2014 and December 31, 2018. Data were from Tianjin Hospital Hip Fracture (THHF) cohort. Follow-up period was until March 31, 2022. Mortality, excess mortality, and comorbidities were analyzed and stratified by therapy and gender. Time dependent Cox models were performed to estimate the effects of the variables.

Results:: Absolute mortality for all the patients was 5.90% at 3 months, 12.55% at 12 months, 19.92% at 24 months and 27.28% at 36 months. Absolute mortality for surgical group was 1.57% at 3 months, 4.77% at 12 months, 8.49% at 24 months and 12.07% at 36 months, significantly lower than conservative group: 10.50% at 3 months, 20.73% at 12 months, 31.96% at 24 months and 43.04% at 36 months. We found a substantially lower mortality (hazard ratio [HR] 0.34, 95% confidence internal, [CI]: 0.23–0.52, p = 0.000) among patients undergoing surgical therapy than those undergoing conservative therapy, even when controlled for gender, age, the length of hospital stay, and all the comorbidities. Female patients (HR 0.68, 95% CI: 0.58–0.79, p = 0.000) were less likely to die than male patients after an intertrochanteric fracture. Patients treated by the two methods were both found to have excess mortality rates compared to the general population, although in different levels. The excess mortality rates for patients in the conservative therapy group were 14.46% in males and 17.93% in females, while in the surgical therapy group, 2.78% in females and 4.37% in males. The comorbidities moderate or severe renal disease (HR 2.19, 95% CI: 1.61–2.98, p = 0.000), metastatic solid tumor (HR 6.35, 95% CI: 1.56–25.85, p = 0.010), hypoproteinemia (HR 1.22, 95% CI: 1.01–1.47, p = 0.034), and older age (HR 1.89, 95% CI: 1.73–2.08, p = 0.000) were also risk factors on mortality. A worse-case analysis for the primary outcome were performed as sensitivity analysis and it was consistent with the original conclusion.

Conclusion:: Intertrochanteric factures for people aged 50 years older were found to have excess mortality compared to the general population in Tianjin city, and preventing the fractures in the hip for elderly people was imperative. After controlling tfor comorbidities and age, female gender and surgical therapy were protective factors for the death after fractures, which could provide strong evidence for patients and surgeons to make decisions.

Keywords

Excess mortality / Mortality / Intertrochanteric fracture / Therapy

References

[1] Xia WB, He SL, Xu L, Liu AM, Jiang Y, Li M, et al. Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res. 2012;27(1):125–129.

[2] Tian FM, Sun XX, Liu JY, Liu ZK, Liang CY, Zhang L. Unparallel gender-specific changes in the incidence of hip fractures in Tangshan, China. Arch Osteoporos. 2017;12(1):18.

[3] Cheung CL, Ang SB, Chadha M, Chow ESL, Chung YS, Hew FL, et al. An updated hip fracture projection in Asia: the Asian Federation of Osteoporosis Societies study. Osteoporos Sarcopenia. 2018;4(1):16–21.

[4] Liu Z, Cheng AG, Bai Z, Lu Y, Endo N, Dohmae Y, et al. Epidemiology of cervical and trochanteric fractures of the proximal femur in 1994 in Tangshan, China. J Bone Miner Metab. 2000;18(2):84–88.

[5] Tian FM, Zhang L, Zhao HY, Liang CY, Zhang N, Song HP. An increase in the incidence of hip fractures in Tangshan, China. Osteoporos Int. 2014;25(4):1321–1325.

[6] Huang KY, Chang JK, Ling SY, Endo N, Takahashi HE. Epidemiology of cervical and trochanteric fractures of the proximal femur in 1996 in Kaohsiung city, Taiwan. J Bone Miner Metab. 2000;18(2):89–95.

[7] Yan L, Zhou B, Prentice A, Wang X, Golden MHN. Epidemiological study of hip fracture in Shenyang, people Republic of China. Bone. 1999;24(2):151–155.

[8] Fox KM, Magaziner J, Hebel JR, Kenzora JE, Kashnei TM. Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae. J Gerontol A Biol Sci Med Sci. 1999;54(12):M635–M640.

[9] Chang SM, Hou ZY, Hu SJ, du SC. Intertrochanteric femur fracture treatment in Asia: what we know and what the world can learn. Orthop Clin North Am. 2020;51(2):189–205.

[10] Gong XF, Li XP, Zhang LX, Center JR, Bliuc D, Shi Y, et al. Current status and distribution of hip fractures among older adults in China. Osteoporos Int. 2021;32(9):1785–1793.

[11] Karagiannis A, Papakitsou E, Dretakis K, Galanos A, Megas P, Lambiris E, et al. Mortality rates of patients with a hip fracture in a southwestern district of Greece: ten-year follow-up with reference to the type of fracture. Calcif Tissue Int. 2006;78(2):72–77.

[12] Forsen L, Sogaard AJ, Meyer HE, et al. Survival after hip fracture: short-and long-term excess mortality according to age and gender. Osteopors Int. 1999;10:73–78.

[13] Paspati I, Galanos A, Lyritis GP. Hip fracture epidemiology in Greece during 1977-1992. Calcif Tissue Int. 1998;62:542–547.

[14] Haentjens P, Autier P, Barette M, Venken K, Vanderschueren D, Boonen S. Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. Bone. 2007;41(6):958–964.

[15] Fragility Fracture Network-China; Academic Committee of Orthopeadic Trauma, Bone and Joint Branch of Chinese Geriatrics Society. Guidelines for management of geriatric femoral intertrochanteric fractures. Chin J Orlliop Frauma. 2020;22(2):93–99.

[16] Handoll HH, Parker MJ. Conservative versus operative treatment for hip fractures in adults. Cochrane Database Syst Rev. 2008;16(3):CD000337.

[17] Kenzora JE, McCarthy RE, Lowell JD, Sledge CB. Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications. Clin Orthop Relat Res. 1984;186:45–56.

[18] Schwarz GM, Hajdu S, Windhager R, Willegger M. The top fifty most influential articles on hip fractures. Int Orthop. 2022;46(10):2437–2453.

[19] Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am. 2005;87(3):483–489.

[20] Tan CMP, Park DH, Chen YD, Jagadish MU, Su S, Premchand AXR. Mortality rates for hip fracture patients managed surgically and conservatively in a dedicated unit in Singapore. Arch Orthop Trauma Surg. 2022;142(1):99–104.

[21] Nikkel LE, Kates SL, Schreck M, Maceroli M, Mahmood B, Elfar JC. Length of hospital stay after hip fracture and risk of early mortality after discharge in New York state: retrospective cohort study. BMJ. 2015;10(351):h6246.

[22] Kim SJ, Park HS, Lee DW. Outcome of nonoperative treatment for hip fractures in elderly patients: a systematic review of recent literature. J Orthop Surg (Hong Kong). 2020;28(2):2309499020936848.

[23] Frenkel Rutenberg T, Assaly A, Vitenberg M, Shemesh S, Burg A, Haviv B, et al. Outcome of non-surgical treatment of proximal femur fractures in the fragile elderly population. Injury. 2019;50(7):1347–1352.

[24] Forte ML, Virnig BA, Swiontkowski MF, Bhandari M, Feldman R, Eberly LE, et al. Ninety-day mortality after intertrochanteric hip fracture: does provider volume matter? J Bone Joint Surg Am. 2018;92(4):799–806.

[25] Mattisson L, Bojan A, Enocson A. Epidemiology, treatment and mortality of trochanteric and subtrochanteric hip fractures: data from the Swedish fracture register. BMC Musculoskelet Disord. 2018;19(1):369.

[26] Leu TH, Chang WC, Lin JC, et al. Incidence and excess mortality of hip fracture in young adults: a nationwide population-based cohort study. BMC Musculoskelet Disord. 2016;17:326.

[27] Office of State Council for the National Population Census. Major data on 2020 population census of China. http://www.stats.gov.cn/sj/pcsj/rkpc/7rp/zk/indexch.htm

[28] Cui S, Zhao L, Wang Y, Dong Q, Ma J, Ma X. Blood biomarkers related to osteonecrosis of femoral head by internal fixation after garden I femoral neck fracture: a cohort study. Injury. 2021;52(11):3427–3433.

[29] Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010;39(2):1–7.

[30] Man LP, Ho AW, Wong SH. Excess mortality for operated geriatric hip fracture in Hong Kong. Hong Kong Med J. 2016;22(1):6–10.

[31] Office of State Council for the National Population Census. Major data on 2010 population census of China. http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm

[32] Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jiang XY. All-cause mortality risk in aged femoral intertrochanteric fracture patients. J Orthop Surg Res. 2021;16(1):727.

[33] Long Y, Wang T, Xu X, Ran G, Zhang H, Dong Q, et al. Risk factors and outcomes of extended length of stay in older adults with intertrochanteric fracture surgery: a retrospective cohort study of 2132 patients. J Clin Med. 2022;11(24):7366.

[34] Cui Z, Feng H, Meng X, Zhuang S, Liu Z, Ye K, et al. Age-specific 1-year mortality rates after hip fracture based on the populations in mainland China between the years 2000 and 2018: a systematic analysis. Arch Osteoporos. 2019;14(1):55.

[35] Guzon-Illescas O, Fernandez EP, Villarias NC, et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019;14(1):203.

[36] Forsén L, Sogaard AJ, Meyer HE, Edna T, Kopjar B. Survival after hip fracture: short- and Long-term excess mortality according to age and gender. Osteoporos Int. 1999;10(1):73–78.

[37] Li SG, Sun TS, Liu Z. Excess mortality of 1 year in elderly hip fracture patients compared with the general population in Beijing, China. Arch Osteoporos. 2016;11(1):35.

[38] Katsoulis M, Benetou V, Karapetyan T, Feskanich D, Grodstein F, Pettersson-Kymmer U, et al. Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med. 2017;281(3):300–310.

[39] Nasab SAM, Khorramdin E. The assessment of mortality and quality of life after intertrochanteric fracture of femur in patients older than 60 at Emam Khomeini Hospital of Ahvaz. Pak J Med Sci. 2017;33(4):895–898.

[40] Giummarra MJ, Ekegren CL, Gong J, Simpson P, Cameron PA, Edwards E, et al. (2020) twelve month mortality rates and independent living in people aged 65 years or older after isolated hip fracture: a prospective registry-based study. Injury. 2020;51(2):420–428.

[41] Zhao F, Wang X, Dou Y, Wang H, Zhang Y. Analysis of risk factors for perioperative mortality in elderly patients with intertrochanteric fracture. Eur J Orthop Surg Traumatol. 2019;29(1):59–63.

[42] Kalem M, Kocaoğlu H, Şahin E, Kocaoğlu MH, Başarır K, Kınık H. Impact of echocardiography on one-month and one-year mortality of intertrochanteric fracture patients. Acta Orthop Traumatol Turc. 2018;52(2):97–100.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.